Calhoun Lesley Ann
SEC insider (Form 3/4/5 filer). CIK 0001730866. Director at Tango Therapeutics, Inc. (TNGX) and 1 other issuer. 6 reported Form 4/5 transactions since Sep 2024; latest on Jun 5, 2026. Located in BOSTON, MA.
Companies Calhoun Lesley Ann has filed insider reports for
- Tango Therapeutics, Inc. (TNGX): Director
- Aligos Therapeutics, Inc. (ALGS): Officer, See Remarks
Calhoun Lesley Ann
CIK: 0001730866
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (6 total)
- Jun 5, 2026TNGX
Tango Therapeutics, Inc.
AwardDirect4K shares- - Mar 9, 2026ALGS
Aligos Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
37.5K shares- - Jul 16, 2025ALGS
Aligos Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
40.2K shares- - Jun 5, 2025TNGX
Tango Therapeutics, Inc.
AwardDirect6.3K shares- - Feb 28, 2025ALGS
Aligos Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
47.3K shares- - Sep 4, 2024ALGS
Aligos Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
10.9K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 5, 2026 |  TNGX Tango Therapeutics, Inc. | Award | 4,000 | - | $0 | Direct |
| Mar 9, 2026 |  ALGS Aligos Therapeutics, Inc. | Award Stock Option (Right to Buy) | 37,485 | - | - | Direct |
| Jul 16, 2025 | ALGS Aligos Therapeutics, Inc. | Award Stock Option (Right to Buy) | 40,185 | - | - | Direct |
| Jun 5, 2025 | TNGX Tango Therapeutics, Inc. | Award | 6,250 | - | - | Direct |
| Feb 28, 2025 | ALGS Aligos Therapeutics, Inc. | Award Stock Option (Right to Buy) | 47,271 | - | - | Direct |
| Sep 4, 2024 | ALGS Aligos Therapeutics, Inc. | Award Stock Option (Right to Buy) | 10,880 | - | - | Direct |
1-6 of 6 transactions